Variations should be designed cautiously as well as the frequency of blood glucose monitoring should be increased. Changes in concomitant oral antidiabetic treatment could possibly be wanted. BRIEF Basic safety STATEMENT: Failure to use the Dexcom Ongoing Glucose Monitoring Program and its elements in accordance with the Guidelines for https://alcuind937aip0.blogvivi.com/profile